|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2011-5-25
|
|
pubmed:abstractText |
Increased cardiovascular morbidity has become a leading cause of mortality in rheumatoid arthritis (RA). Tumor necrosis factor-alpha (TNFa) inhibitors may influence flow-mediated vasodilation (FMD) of the brachial artery, common carotid intima-media thickness (ccIMT) and arterial stiffness indicated by pulse-wave velocity (PWV) in RA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
1565-1088
|
|
pubmed:author |
pubmed-author:CsáthyLászlóL,
pubmed-author:DérHenriettH,
pubmed-author:KerekesGyörgyG,
pubmed-author:SoltészPálP,
pubmed-author:SzabóZoltánZ,
pubmed-author:SzamosiSzilviaS,
pubmed-author:SzegediGyulaG,
pubmed-author:SzekaneczZoltánZ,
pubmed-author:SzodorayPeterP,
pubmed-author:SzucsGabriellaG,
pubmed-author:VáncsaAndreaA
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
13
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
147-52
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:21608334-Adult,
pubmed-meshheading:21608334-Aged,
pubmed-meshheading:21608334-Antibodies, Monoclonal,
pubmed-meshheading:21608334-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:21608334-Antirheumatic Agents,
pubmed-meshheading:21608334-Arthritis, Rheumatoid,
pubmed-meshheading:21608334-Atherosclerosis,
pubmed-meshheading:21608334-Brachial Artery,
pubmed-meshheading:21608334-Carotid Artery, Common,
pubmed-meshheading:21608334-Elasticity,
pubmed-meshheading:21608334-Endothelium, Vascular,
pubmed-meshheading:21608334-Female,
pubmed-meshheading:21608334-Humans,
pubmed-meshheading:21608334-Male,
pubmed-meshheading:21608334-Middle Aged,
pubmed-meshheading:21608334-Vascular Diseases,
pubmed-meshheading:21608334-Vasodilation,
pubmed-meshheading:21608334-von Willebrand Factor
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
|
|
pubmed:affiliation |
Cardiovascular Unit, Third Department of Medicine, University of Debrecen Medical and Health Science Center, Debrecen, Hungary.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
